Key Client Fiduciary Advisors »

Humacyte shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.1k 12k 0.78

More positions owned by Key Client Fiduciary Advisors

Galaxy Digital Cl A Put Option (GLXY)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Nasdaq Cyb Etf (CIBR)
Apple (AAPL)
Putnam Etf Trust Focused Lar Cap (PVAL)
First Tr Exchange-traded SHS (FDL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Us Consm Staples (IYK)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Us Garp Etf (GARP)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)

View all positions for Key Client Fiduciary Advisors

Top funds holding Humacyte

BlackRock
Vanguard Capital Management
Antipodes Partners
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
AQR Capital Management
Susquehanna International
Vanguard Portfolio Management
Charles Schwab Investment Management
Northern Trust
Vanguard Fiduciary Trust
LPL Financial

View all funds holding Humacyte